Mpox outbreak study in the Democratic Republic of Congo
Part of Infections clinical trials.
This study is for people in the Democratic Republic of Congo who have been diagnosed with mpox. Researchers want to learn more about how the virus spreads and how it affects people during this outbreak.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a lab test (like a PCR test) that confirmed you have mpox.
- You must have deep-seated, firm blisters or pustules on your skin.
- You must have had at least one of these: fever before the rash appeared, swollen lymph nodes (in the groin, armpit, or neck), or pustules on the palms of your hands or soles of your feet.
- You (or someone you trust) must agree to participate and sign the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an MVA-based vaccine (MVA-SIBP) to see if it is safe and creates a good immune response against smallpox and mpox. It's for healthy people in certain age groups who have not had these vaccines or infections before.
This study tests people for VMPX to learn more about the condition and to understand how it affects the body. You can join if you are willing to be tested and can give permission.
This study is looking at people with mpox in the DR Congo to learn more about the outbreak. If you have a rash that fits the mpox pattern and a positive lab test, you may be able to join.
This study looks at the mpox outbreak in Equateur Province, Democratic Republic of Congo. It aims to understand who gets sick and how the virus spreads, which may help with future prevention.
This study tests whether a single dose of the LC16m8 mpox vaccine is safe and works in people living in the Democratic Republic of Congo. It also monitors for side effects and tracks mpox cases to see how well the vaccine protects the community.
This study in West Africa follows people with confirmed mpox (monkeypox) infection and their close contacts to understand how the virus spreads, clears from the body, and how well the mpox vaccine protects people. You may be eligible if you've recently tested positive for mpox, were exposed to someone with mpox, or live in an area offering mpox vaccination.
Hear when a new Monkeypox (Mpox) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.